Prognostic risk factors and the role of systemic inflammatory response index in predicting outcomes for non-muscle-invasive bladder cancer
SIRI is a significant predictor of disease progression in NMIBC, although it is not associated with RFS. When combined with clinicopathological factors such as tumor stage, grade, count, and primary diagnosis status, SIRI can enhance risk stratification in NMIBC, aiding personalized management.
Authors
- Qi Gui (ORCID: https://orcid.org/0000-0001-7702-1887)
- Xiang Jiao (ORCID: https://orcid.org/0000-0001-8043-3719)
- Taiyang Liu (ORCID: https://orcid.org/0009-0002-9701-1656)
- Xiuhua Wen
- Hongwei Guo
Institutions
- Zhumadian Central Hospital (CN)
- Huanghuai University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.3389/fonc.2025.1646723
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Henan Provincial Science and Technology Research Project